“We assessed clinical practice standards for infectious complications among pediatric blood and marrow transplant (PBMT) recipients” Azim et al (2015).
Reference:
Azim, H.A., Balian, C., Tewari, P., Santizo, R., Kapoor, N. and Mahadeo, K.M. (2015) A survey of infectious disease clinical practices among pediatric blood and marrow transplant programs in the United States. Pediatric Blood & Cancer. 3rd January. [epub ahead of print].
[ctt tweet=”Infectious complications among pediatric blood and marrow transplant recipients http://ctt.ec/1miw5+ @ivteam #ivteam” coverup=”1miw5″]
Abstract:
We assessed clinical practice standards for infectious complications among pediatric blood and marrow transplant (PBMT) recipients. An anonymous online survey was sent to all 64 pediatric program directors (PD) of PBMT centers in the United States, which are accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). The overall response rate was 56% (CI: 44–68%); variations in clinical practices were noted regarding (i) surveillance for late onset cytomegalovirus (CMV) infection and (ii) pharmacokinetic/therapeutic drug monitoring of antimicrobials. Prospective studies among PBMT recipients to address infectious complications among this population and variations in clinical practice may be required.
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]